Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice

Yunping Deng, T. Wong, C. Bricker-Anthony, B. Deng, Anton Reiner

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Motor slowing, forebrain white matter loss, and striatal shrinkage have been reported in premanifest Huntington's disease (HD) prior to overt striatal neuron loss. We carried out detailed LM and EM studies in a genetically precise HD mimic, heterozygous Q140 HD knock-in mice, to examine the possibility that loss of corticostriatal and thalamostriatal terminals prior to striatal neuron loss underlies these premanifest HD abnormalities. In our studies, we used VGLUT1 and VGLUT2 immunolabeling to detect corticostriatal and thalamostriatal (respectively) terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathology. VGLUT1 + axospinous corticostriatal terminals represented about 55% of all excitatory terminals in striatum, and VGLUT2 + axospinous thalamostriatal terminals represented about 35%, with VGLUT1 + and VGLUT2 + axodendritic terminals accounting for the remainder. In Q140 mice, a significant 40% shortfall in VGLUT2 + axodendritic thalamostriatal terminals and a 20% shortfall in axospinous thalamostriatal terminals were already observed at 1. month of age, but VGLUT1 + terminals were normal in abundance. The 20% deficiency in VGLUT2 + thalamostriatal axospinous terminals persisted at 4 and 12. months in Q140 mice, and an additional 30% loss of VGLUT1 + corticostriatal terminals was observed at 12. months. The early and persistent deficiency in thalamostriatal axospinous terminals in Q140 mice may reflect a development defect, and the impoverishment of this excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. The loss of corticostriatal terminals at 1. year in Q140 mice is consistent with prior evidence from other mouse models of corticostriatal disconnection early during progression, and can explain both the measurable bradykinesia and striatal white matter loss in late premanifest HD.

Original languageEnglish (US)
Pages (from-to)89-107
Number of pages19
JournalNeurobiology of Disease
Volume60
DOIs
StatePublished - Dec 1 2013

Fingerprint

Corpus Striatum
Huntington Disease
Presynaptic Terminals
Pathology
Neurons
Hypokinesia
Prosencephalon

All Science Journal Classification (ASJC) codes

  • Neurology

Cite this

@article{e5898d22f6a246a2aeaf12201f8e5977,
title = "Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice",
abstract = "Motor slowing, forebrain white matter loss, and striatal shrinkage have been reported in premanifest Huntington's disease (HD) prior to overt striatal neuron loss. We carried out detailed LM and EM studies in a genetically precise HD mimic, heterozygous Q140 HD knock-in mice, to examine the possibility that loss of corticostriatal and thalamostriatal terminals prior to striatal neuron loss underlies these premanifest HD abnormalities. In our studies, we used VGLUT1 and VGLUT2 immunolabeling to detect corticostriatal and thalamostriatal (respectively) terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathology. VGLUT1 + axospinous corticostriatal terminals represented about 55{\%} of all excitatory terminals in striatum, and VGLUT2 + axospinous thalamostriatal terminals represented about 35{\%}, with VGLUT1 + and VGLUT2 + axodendritic terminals accounting for the remainder. In Q140 mice, a significant 40{\%} shortfall in VGLUT2 + axodendritic thalamostriatal terminals and a 20{\%} shortfall in axospinous thalamostriatal terminals were already observed at 1. month of age, but VGLUT1 + terminals were normal in abundance. The 20{\%} deficiency in VGLUT2 + thalamostriatal axospinous terminals persisted at 4 and 12. months in Q140 mice, and an additional 30{\%} loss of VGLUT1 + corticostriatal terminals was observed at 12. months. The early and persistent deficiency in thalamostriatal axospinous terminals in Q140 mice may reflect a development defect, and the impoverishment of this excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. The loss of corticostriatal terminals at 1. year in Q140 mice is consistent with prior evidence from other mouse models of corticostriatal disconnection early during progression, and can explain both the measurable bradykinesia and striatal white matter loss in late premanifest HD.",
author = "Yunping Deng and T. Wong and C. Bricker-Anthony and B. Deng and Anton Reiner",
year = "2013",
month = "12",
day = "1",
doi = "10.1016/j.nbd.2013.08.009",
language = "English (US)",
volume = "60",
pages = "89--107",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice

AU - Deng, Yunping

AU - Wong, T.

AU - Bricker-Anthony, C.

AU - Deng, B.

AU - Reiner, Anton

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Motor slowing, forebrain white matter loss, and striatal shrinkage have been reported in premanifest Huntington's disease (HD) prior to overt striatal neuron loss. We carried out detailed LM and EM studies in a genetically precise HD mimic, heterozygous Q140 HD knock-in mice, to examine the possibility that loss of corticostriatal and thalamostriatal terminals prior to striatal neuron loss underlies these premanifest HD abnormalities. In our studies, we used VGLUT1 and VGLUT2 immunolabeling to detect corticostriatal and thalamostriatal (respectively) terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathology. VGLUT1 + axospinous corticostriatal terminals represented about 55% of all excitatory terminals in striatum, and VGLUT2 + axospinous thalamostriatal terminals represented about 35%, with VGLUT1 + and VGLUT2 + axodendritic terminals accounting for the remainder. In Q140 mice, a significant 40% shortfall in VGLUT2 + axodendritic thalamostriatal terminals and a 20% shortfall in axospinous thalamostriatal terminals were already observed at 1. month of age, but VGLUT1 + terminals were normal in abundance. The 20% deficiency in VGLUT2 + thalamostriatal axospinous terminals persisted at 4 and 12. months in Q140 mice, and an additional 30% loss of VGLUT1 + corticostriatal terminals was observed at 12. months. The early and persistent deficiency in thalamostriatal axospinous terminals in Q140 mice may reflect a development defect, and the impoverishment of this excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. The loss of corticostriatal terminals at 1. year in Q140 mice is consistent with prior evidence from other mouse models of corticostriatal disconnection early during progression, and can explain both the measurable bradykinesia and striatal white matter loss in late premanifest HD.

AB - Motor slowing, forebrain white matter loss, and striatal shrinkage have been reported in premanifest Huntington's disease (HD) prior to overt striatal neuron loss. We carried out detailed LM and EM studies in a genetically precise HD mimic, heterozygous Q140 HD knock-in mice, to examine the possibility that loss of corticostriatal and thalamostriatal terminals prior to striatal neuron loss underlies these premanifest HD abnormalities. In our studies, we used VGLUT1 and VGLUT2 immunolabeling to detect corticostriatal and thalamostriatal (respectively) terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathology. VGLUT1 + axospinous corticostriatal terminals represented about 55% of all excitatory terminals in striatum, and VGLUT2 + axospinous thalamostriatal terminals represented about 35%, with VGLUT1 + and VGLUT2 + axodendritic terminals accounting for the remainder. In Q140 mice, a significant 40% shortfall in VGLUT2 + axodendritic thalamostriatal terminals and a 20% shortfall in axospinous thalamostriatal terminals were already observed at 1. month of age, but VGLUT1 + terminals were normal in abundance. The 20% deficiency in VGLUT2 + thalamostriatal axospinous terminals persisted at 4 and 12. months in Q140 mice, and an additional 30% loss of VGLUT1 + corticostriatal terminals was observed at 12. months. The early and persistent deficiency in thalamostriatal axospinous terminals in Q140 mice may reflect a development defect, and the impoverishment of this excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. The loss of corticostriatal terminals at 1. year in Q140 mice is consistent with prior evidence from other mouse models of corticostriatal disconnection early during progression, and can explain both the measurable bradykinesia and striatal white matter loss in late premanifest HD.

UR - http://www.scopus.com/inward/record.url?scp=84884134047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884134047&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2013.08.009

DO - 10.1016/j.nbd.2013.08.009

M3 - Article

VL - 60

SP - 89

EP - 107

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -